Advert - Colonis

• Date posted
  25 September 2020
• Sanction
  Advertisement,
• Case number/s
  AUTH/3240/8/19 - Voluntary admission from Colonis

For failing to identify during the approval process that the
incorrect prescribing information had been included in a
promotional letter about Melatonin 1mg/ml oral solution,
Colonis was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 4.1 - Failing to include up-to-date prescribing information

Clause 9.1 - Failing to maintain high standards

In addition, the Code of Practice Appeal Board required Colonis to be publicly reprimanded for its failure to provide complete and accurate information to the Code of Practice Panel.